Shipping cost is based on weight. Just add products to your cart and use the Shipping Calculator to see the shipping price.
We want you to be 100% satisfied with your purchase. Items can be returned or exchanged within 30 days of delivery.
A Product Overview
What Fibrovita® Treats
- Fibrovita targets the fibrin mesh supporting fibroids.
- Fibroids depend on abnormal fibrin build-up for growth and support..
- Without the fibrin base, fibroids are naturally cleared by the liver and kidneys.
- Fibrovita addresses the root cause of ovarian cyst pain.
- Ovarian cyst pain often results from fibrin adhesions caused by collapsed or recurrent cysts.
- As fibrin is removed, ovarian cyst adhesions are naturally cleared by the liver and kidneys.
- Fibrovita targets the root of endometrial adhesions.
- Endometrial adhesions mainly consist of abnormal fibrin, causing endometriosis pain..
- Without fibrin, endometrial adhesions are naturally cleared by the liver and kidneys.
- Fibrovita addresses fibrin causing fibrocystic breast lumps.
- Fibrocystic breast lumps result from abnormal fibrin build-up.
- Nattokinase NSP-2™ in Fibrovita increases fibrinolytic activity, softening and clearing breast lumps.
Uterine fibroids, noncancerous growths in the uterus, are common, especially among women of childbearing age. They can lead to symptoms such as heavy menstrual bleeding, pelvic pain, and pressure. Diagnosis is usually made through pelvic exams and imaging tests.
These growths may affect fertility and cause complications during pregnancy, making early detection and management essential for women experiencing symptoms or planning to start a family. While some fibroids may not cause any discomfort or require immediate intervention, others can significantly impact a woman's quality of life.
About Ovarian Cyst
Ovarian cysts are fluid-filled sacs that can develop on or within the ovaries. They are common and often asymptomatic, but when symptoms do occur, they can include pelvic pain, bloating, and changes in menstrual cycles. Most ovarian cysts are benign and resolve on their own, but medical evaluation is crucial if they persist, grow, or cause severe symptoms. Treatment options range from watchful waiting to medication or surgery, depending on the specific circumstances. Consulting a healthcare provider is essential for proper diagnosis and management of ovarian cysts.
Endometriosis is a chronic medical condition that primarily affects individuals with a uterus, typically during their reproductive years. It occurs when tissue similar to the lining of the uterus, called the endometrium, starts growing outside the uterus. This abnormal tissue growth can occur on various pelvic organs, such as the ovaries, fallopian tubes, and the lining of the pelvic cavity.
The hallmark symptom of endometriosis is pelvic pain, which can range from mild to severe and often becomes more intense during menstruation. Other common symptoms include heavy menstrual bleeding, pain during intercourse, painful bowel movements or urination, and infertility. While the exact cause of endometriosis remains unclear, hormonal factors, genetic predisposition, and immune system dysfunctioEn are believed to play a role. Diagnosis is typically confirmed through laparoscopic surgery, and treatment options may include pain management, hormonal therapy, or surgical intervention to remove or manage endometrial implants. Endometriosis can significantly impact a person's quality of life, and ongoing medical management is often necessary to alleviate symptoms and improve overall well-being.
About Breast Lumps
Breast lumps are abnormal growths or masses that can develop in the breast tissue. They can vary in size, texture, and characteristics, and while many breast lumps are noncancerous (benign), some may be indicative of breast cancer. Common causes of benign breast lumps include fibrocystic changes, which involve the development of fluid-filled cysts or fibrous tissue, and benign tumors like fibroadenomas. It is crucial for individuals who detect a breast lump to seek prompt medical evaluation, as breast lumps can be evaluated through clinical examination, imaging studies like mammography or ultrasound, and, if necessary, through biopsy to determine their nature and guide appropriate treatment or monitoring. Regular breast self-exams and routine breast screenings are essential for early detection and timely intervention, as early diagnosis and treatment of breast lumps, particularly if they are cancerous, can significantly impact prognosis and treatment outcomes.
- Vitamin B6 (as Pyridoxal 5' Phosphate)
- Nattokinase NSP-2
- Proprietary Blend:
- GLA (Gamma Linolenic Acid)
- DIM (Diindolylmethane)
- 5 HTP
- Black Cohosh Root
Vitamin B6, particularly in its active form known as Pyridoxal 5' Phosphate (PLP), offers several benefits for women's health. PLP plays a crucial role in hormone regulation, helping to balance estrogen and progesterone levels, which can alleviate symptoms of PMS (premenstrual syndrome) and menopause, including mood swings, bloating, and breast tenderness. Additionally, PLP supports neurotransmitter production, contributing to stable moods and emotional well-being, which can be especially significant during hormonal fluctuations. Moreover, PLP aids in the formation of antibodies and immune cells, enhancing the body's ability to combat infections and maintain overall health. It is worth noting that maintaining an appropriate balance of vitamin B6 is essential, as excessive intake can lead to neurological issues, so women should aim to meet their nutritional needs through a well-rounded diet and consult with a healthcare provider before considering supplements.
Nattokinase NSP-2™ in Fibrovita increases fibrinolytic activity, degrading excess fibrin. Nattokinase NSP-2, derived from fermented soybeans, is often suggested for its potential benefits in women's health conditions like fibroids, ovarian cysts, endometriosis, and breast lumps. Nattokinase NSP-2 is an enzyme derived from natto, a traditional Japanese fermented soybean product. It has gained attention for its potential health benefits, including its ability to promote cardiovascular health.
The combination of Gamma Linolenic Acid (GLA), Diindolylmethane (DIM), 5-HTP, Black Cohosh Root, and PEA in a proprietary blend is often suggested as a potential treatment for women's health conditions like fibroids, ovarian cysts, endometriosis, and breast lumps. Here's a general overview of how these components are believed to work together:
1. Gamma Linolenic Acid (GLA): GLA is an omega-6 fatty acid found in various plant-based oils like evening primrose oil and borage oil. It is thought to have anti-inflammatory properties and may help regulate hormonal imbalances, which can contribute to conditions like fibroids and endometriosis.
2. Diindolylmethane (DIM): DIM is a compound found in cruciferous vegetables like broccoli and cauliflower. It is believed to support hormonal balance by aiding the metabolism of estrogen. In conditions like fibroids, where hormonal factors play a role, DIM helps regulate estrogen levels.
3. 5-HTP (5-Hydroxytryptophan): 5-HTP is a precursor to serotonin, a neurotransmitter that can influence mood and well-being. Its inclusion may help address mood-related symptoms often associated with women's health conditions like PMS, which can be present alongside fibroids, ovarian cysts, endometriosis, and breast lumps.
4. Black Cohosh Root: Black Cohosh is a traditional herbal remedy that has been used to manage menopausal symptoms like hot flashes and mood swings. In women's health conditions, it may help alleviate discomfort associated with hormonal fluctuations.
5. PEA (Palmitoylethanolamide): PEA is a naturally occurring fatty acid that is believed to have anti-inflammatory and pain-relieving properties. It is included to help manage pain and inflammation associated with conditions like endometriosis and breast lumps.
While these components have benefits on their own, it's important for individuals with these conditions to consult with healthcare professionals for evidence-based treatment options and personalized care, as the most appropriate approach to management may vary from person to person.
What to Expect
In the initial one to two months of using Fibro Vita® for uterine fibroids, you can expect significant changes as your body responds to the treatment. These changes include symptom improvement, such as lighter menstrual bleeding, reduced abdominal discomfort, improved energy levels, enhanced intimacy, and digestive relief. Early treatment phases may also bring temporary effects like darker urine, minor cramping, and a more watery menstrual flow, which are manageable and part of your body's response to treatment.
As you continue Fibro Vita® treatment, your body will keep breaking down excess fibrin deposits, leading to ongoing improvement. However, patience is essential, as fibroids typically develop over several years. Long-term management may be necessary to address excess fibrin production, and some choose to take Fibro Vita® as needed for symptom relief, while others use it continuously as a proactive measure. It's important to note that individual responses may vary, and if you don't experience benefits after 60 days, consult your doctor for alternative treatment options. Ultimately, managing uterine fibroids with Fibro Vita® is a gradual process that leads to symptom relief and better reproductive health.